Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lafutidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102212060A details a novel aminolysis route for Lafutidine, eliminating dihydro impurities and offering significant cost reduction in pharmaceutical manufacturing.
Novel patent CN103130782A details a hydroxylamine-based route for Lafutidine intermediates, eliminating dihydro impurities and ensuring 99.88% purity for reliable API manufacturing.
Novel hydroxylamine hydrochloride route for Lafutidine improves purity to 99.88% and reduces impurities significantly for reliable pharmaceutical intermediates supply chain stability.